Evaluation of a Test Dose Strategy for Pharmacokinetically-Guided Busulfan Dosing for Hematopoietic Stem Cell Transplantation-Reference-Cited by-同舟云学术

Evaluation of a Test Dose Strategy for Pharmacokinetically-Guided Busulfan Dosing for Hematopoietic Stem Cell Transplantation

Published:2019-02 Issue:2 Volume:25 Page:391-397
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Davis Jessica M.,Ivanova Anastasia,Chung Yunro,Shaw J. Ryan,Rao Kamakshi V.,Ptachcinski Jonathan R.,Sharf Andrew A.,Serody Jonathan S.,Armistead Paul M.^ORCID,Wood William A.^ORCID,Coghill James M.,Jamieson Katarzyna J.,Vincent Benjamin G.,Riches Marcie L.,Shea Thomas C.,Alexander Maurice D.^ORCID

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference31 articles.

1. Busulfan in hematopoietic stem cell transplantation;Ciurea;Biol Blood Marrow Transplant,2009

2. The effect of busulphan on the pharmacokinetics of cyclophosphamide and its 4-hydroxy metabolite: time interval influence on therapeutic efficacy and therapy-related toxicity;Hassan;Bone Marrow Transplant,2000

3. Busulfan disposition: the role of therapeutic monitoring in bone marrow transplantation induction regimens;Grochow;Semin Oncol,1993

4. Pharmacokinetics of busulfan: correlation with veno-occlusive disease in patients undergoing bone marrow transplantation;Grochow;Cancer Chemother Pharmacol,1989

5. Acute safety and pharmacokinetics of intravenous busulfan when used with oral busulfan and cyclophosphamide as pretransplantation conditioning therapy: a phase I study;Andersson;Biol Blood Marrow Transplant,2000

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Population Pharmacokinetic Modeling for Twice-Daily Intravenous Busulfan in a Large Cohort of Pediatric Patients Undergoing Hematopoietic Stem Cell Transplantation—A 10-Year Single-Center Experience;Pharmaceutics;2023-12-20

2. Pharmacokinetic Modeling and Simulation with Pharmacogenetic Insights Support the Relevance of Therapeutic Drug Monitoring for Myeloablative Busulfan Dosing in Adult HSCT;Transplantation and Cellular Therapy;2023-12

3. Predicting busulfan exposure in patients undergoing hematopoietic stem cell transplantation using machine learning techniques;Expert Review of Clinical Pharmacology;2023-06-20

4. Utilization of a Population Pharmacokinetic Model to Improve a Busulfan Test‐Dose Strategy in Allogeneic Hematopoietic Cell Transplant Recipients;The Journal of Clinical Pharmacology;2023-06-09

5. Individualizing busulfan dose in specific populations and evaluating the risk of pharmacokinetic drug-drug interactions;Expert Opinion on Drug Metabolism & Toxicology;2023-02-01